EXOTHERA Revenue and Competitors
Estimated Revenue & Valuation
- EXOTHERA's estimated annual revenue is currently $28.4M per year.
- EXOTHERA's estimated revenue per employee is $155,000
Employee Data
- EXOTHERA has 183 Employees.
- EXOTHERA grew their employee count by -19% last year.
EXOTHERA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Technology Officer | Reveal Email/Phone |
2 | MarCom Business Partner at EXOTHERA | Reveal Email/Phone |
EXOTHERA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.6M | 49 | 29% | N/A | N/A |
#2 | $19.8M | 128 | -14% | N/A | N/A |
#3 | $249.2M | 1608 | 5% | N/A | N/A |
#4 | $28.4M | 183 | -19% | N/A | N/A |
#5 | $7.1M | 46 | 5% | $30.5M | N/A |
#6 | $5M | 32 | -9% | N/A | N/A |
#7 | $16.6M | 107 | 45% | N/A | N/A |
#8 | $6.7M | 43 | 48% | N/A | N/A |
#9 | $24.2M | 156 | -16% | N/A | N/A |
#10 | $13.8M | 89 | 31% | N/A | N/A |
What Is EXOTHERA?
Exothera is a viral vector contract manufacturing and development organization (CDMO) using standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.
keywords:N/A
N/A
Total Funding
183
Number of Employees
$28.4M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EXOTHERA News
The scale-up manufacturing process will leverage Exothera's expertise using the NevoLi-ne Upstream platform (integrating the intensified...
ReiThera and Exothera are partnering to develop what they call a large-scale, low cost per dose manufacturing process to deliver novel...
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and...
Other Companies in Nivelles
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.4M | 183 | -19% | N/A |
#2 | $72.4M | 205 | 28% | N/A |
#3 | $54.4M | 218 | 61% | N/A |
#4 | $64.5M | 321 | 44% | N/A |
#5 | $158.7M | 782 | 22% | N/A |